Suppr超能文献

胃肠道组织胞浆菌病伴小肠穿孔:20 年经验。

Gastrointestinal histoplasmosis with small intestinal perforation: 20-year experience.

机构信息

Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

出版信息

Updates Surg. 2024 Jun;76(3):1015-1023. doi: 10.1007/s13304-024-01797-4. Epub 2024 Mar 20.

Abstract

Postmortem studies show gastrointestinal tract involvement in as many as 70% of patients affected by disseminated histoplasmosis. Although gastrointestinal involvement is common in disseminated disease, the presentation of small intestinal perforation is exceedingly rare with few reported cases in the literature. Herein we present our institutional case series. The aim of the study is to describe small intestinal perforation in gastrointestinal histoplasmosis with attention to management and outcomes. This is a retrospective single-institution review of patients ≥ 18 years of age treated for small intestinal perforation due to gastrointestinal histoplasmosis. A prospectively maintained institutional database was searched from 2002 to 2022. Data obtained included demographics, comorbidities, treatment course, and outcomes. Five patients with a mean age of 54 years (range 25-72) were identified. Pertinent underlying comorbid conditions included Crohn's disease, psoriatic arthritis, rheumatoid arthritis, and solid organ transplantation. All patients were on chronic immunosuppressive medication(s) with the most common being tumor necrosis factors alpha inhibitors and corticosteroids. Four had a clinical diagnosis of perforation based on physical examination and imaging. All patients underwent segmental resection(s) of the small intestine and received medical treatment with intravenous amphotericin B and eventual transition to an oral antifungal. No patients experienced complications related to surgery. The limitations of the study include nonrandomized retrospective review, single-institution experience, and small patient sample size. Although rare, histoplasmosis should be considered in the differential of patients on chronic immunosuppressive therapy who present with gastrointestinal symptoms concerning perforation, especially from endemic areas. Small intestinal perforation due to gastrointestinal histoplasmosis can be successfully treated with resection and antifungal therapy.

摘要

尸检研究表明,在患有播散性组织胞浆菌病的患者中,多达 70%的患者存在胃肠道受累。尽管胃肠道受累在播散性疾病中很常见,但小肠穿孔的表现极为罕见,文献中报道的病例很少。在此,我们报告了我们机构的病例系列。本研究的目的是描述胃肠道组织胞浆菌病中的小肠穿孔,并关注其治疗和结局。这是一项回顾性的单机构研究,纳入了 2002 年至 2022 年期间因胃肠道组织胞浆菌病导致小肠穿孔而接受治疗的年龄≥18 岁的患者。从一个前瞻性维护的机构数据库中搜索了数据。获得的数据包括人口统计学、合并症、治疗过程和结局。确定了 5 名平均年龄为 54 岁(范围 25-72 岁)的患者。相关的潜在合并症包括克罗恩病、银屑病关节炎、类风湿关节炎和实体器官移植。所有患者均正在接受慢性免疫抑制药物治疗(最常见的是肿瘤坏死因子-α抑制剂和皮质类固醇)。4 名患者根据体格检查和影像学检查诊断为穿孔。所有患者均接受了小肠节段切除术,并接受了静脉注射两性霉素 B 和最终转为口服抗真菌药物的治疗。没有患者出现与手术相关的并发症。本研究的局限性包括非随机回顾性研究、单机构经验和小样本量。尽管罕见,但对于正在接受慢性免疫抑制治疗且出现与穿孔相关的胃肠道症状的患者,尤其是来自流行地区的患者,应考虑组织胞浆菌病的鉴别诊断。由于胃肠道组织胞浆菌病引起的小肠穿孔可以通过切除和抗真菌治疗成功治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验